Aptus Capital Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Aptus Capital Advisors's EXEL Position: Q2 2026 in Review
Aptus Capital Advisors reduced its Exelixis (EXEL) stake by 14% in Q2 2026, selling an estimated $40.5K and leaving 5,118 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #979.
Aptus Capital Advisors first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Aptus Capital Advisors held 5,118 shares of Exelixis worth $278K as of Q2 2026.
- Aptus Capital Advisors sold 832 Exelixis shares in Q2 2026, an estimated $40.5K.
- Exelixis made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #979 holding.
- Aptus Capital Advisors first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.